Doce-Ace Rtu 120mg - Docetaxel Injection

Price 21000.0 INR/ Piece

Get a Price/Quote

MOQ : 1 Bottle

Doce-Ace Rtu 120mg - Docetaxel Injection Specification

Origin
INDIA

Indication
Breast cancer, NSCLC, prostate cancer, gastric cancer, and head & neck cancer

Salt Composition
Docetaxel Injection

Dosage Form
Injection

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
N/A

Temperature Needed For Fermentation
25 Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Enzymatic Activity
Microtubule inhibitor (Taxane)

Storage Instructions
Store below 25 C; protect from light. Do not freeze.

Shelf Life
24 Months

Doce-Ace Rtu 120mg - Docetaxel Injection Trade Information

Minimum Order Quantity
1 Bottle

FOB Port
DELHI

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Bottles Per Month

Delivery Time
5 Days

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
BOTTLE

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
N/A

About Doce-Ace Rtu 120mg - Docetaxel Injection

Docetaxel is a chemotherapy medication that was approved to be used for its medical use on 19th May 2004.
Uses of DOCETAXELDocetaxel is indicated for treating different types of cancers, which include the following, non-small cell lung cancer, breast cancer, prostate cancer, stomach cancer and head and neck cancer.
How is DOCETAXEL administered?Docetaxel concentrate for solution for infusion (injections) is available in three doses of 20mg, 80mg and 120mg.
Side Effects of DOCETAXELSide effects: The common side effects that are likely to occur while you are on the treatment with Docetaxel are headache, dizziness, fever, infections, loss of appetite, joint and muscle pain, trouble sleeping, low blood cell count, nausea, vomiting, high blood pressure, abdominal pain, feeling tired, dry mouth, changes in taste, eye problems, bleeding from nose, hair loss, low blood pressure, rapid heartbeat, diarrhea and constipation.